Khadija Saeed, Author at TechStock²

AXSM Stock Today (Nov. 25, 2025): Axsome Therapeutics Near Record Highs on 63% Revenue Surge

New York — November 25, 2025 — Axsome Therapeutics (NASDAQ: AXSM) heads into Tuesday’s session trading just below fresh record highs, powered by blockbuster growth from its depression drug Auvelity, the launch of migraine pill Symbravo, and a rapidly expanding

25 November 2025

NASDAQ:AXSM

ALT Stock Today (November 25, 2025): Altimmune Extends Rally as Pemvidutide Nears Critical FDA Moment

Key Takeaways ALT stock price today: how Altimmune is trading on November 25, 2025 Altimmune Inc. (NASDAQ: ALT) continues its November rebound. As of early trading on Tuesday, November 25, ALT is changing hands around $5.1 per share, roughly flat

25 November 2025

Rheinmetall Stock (RHM.DE) on 25 November 2025: Share Price Slump, 2030 Super‑Cycle and What Investors Should Watch Now

Frankfurt am Main – 25 November 2025 After one of the sharpest pullbacks in its multi‑year rally, German defence group Rheinmetall AG (Xetra: RHM, ticker: RHM.DE) enters Tuesday’s session under close watch. The stock is trading almost 20% below its

25 November 2025

Defense Industry · Investing · Market Trends · Share Analysis · Stock Market

SRPT Stock Today, November 25, 2025: Sarepta Rises on SRP‑1003 Progress While Elevidys Risks Still Loom

Shares of Sarepta Therapeutics (NASDAQ: SRPT) head into Tuesday’s session trying to build on a rare rally, as investors digest a positive safety update for its experimental RNA therapy SRP‑1003 and weigh it against fresh FDA warnings and trial setbacks

25 November 2025

Biotechnology · Financial News · Investments · NASDAQ:ARWR · NASDAQ:SRPT · Pharmaceuticals · Stock Market

RUM Stock Today (Nov. 25, 2025): Rumble Surges as Tether Bets Bigger and AI Cloud Pivot Takes Shape

Rumble Inc. (NASDAQ: RUM) heads into Tuesday’s session on the back of one of its strongest two-day moves of 2025, fueled by fresh commitments from crypto giant Tether and a transformational AI infrastructure deal with Germany’s Northern Data. As of

25 November 2025

Artificial Intelligence · Cryptocurrency · Financial News · NASDAQ:RUM · Stock Market · Technology

NUAI Stock Soars on Texas AI Campus Expansion: New Era Energy & Digital Update for November 25, 2025

New Era Energy & Digital, Inc. (NASDAQ: NUAI) heads into Tuesday’s session on the back of a sharp rally and a major expansion update for its flagship Texas AI data center project. As of Monday’s close on November 24, NUAI

25 November 2025

Artificial Intelligence · Company News · Digital Innovation · Energy Sector · NASDAQ:NUAI · Stock Market

Kohl’s (KSS) Stock Today, November 25, 2025: New CEO, Q3 Earnings on Deck and a Big Holiday Test

Kohl’s Corporation (NYSE: KSS) heads into a high‑stakes trading day on Tuesday, November 25, 2025, with a fresh CEO, an earnings report due, and the holiday shopping season ramping up—all against a backdrop of heavy short interest and lingering doubts

25 November 2025

Corporate Leadership · Earnings Reports · Holiday Shopping · NYSE:KSS · Retail Industry · Stock Market

Dell Stock (DELL) Today: AI Server Boom Meets Margin Jitters Ahead of Q3 Earnings – November 25, 2025

Dell Technologies stock is back under the spotlight today as investors brace for the company’s third‑quarter fiscal 2026 earnings report after the closing bell. Dell shares finished Monday, November 24, at $127.22, up about 3.8% on the day, but still

25 November 2025

Artificial Intelligence · Earnings Reports · Investment Analysis · NYSE:DELL · Stock Market · Technology

PSTV Stock on November 25, 2025: FDA Meeting, Nasdaq Extension and Humana Deal Put Plus Therapeutics Back in Focus

As traders log in on Tuesday, November 25, 2025, Plus Therapeutics (NASDAQ:PSTV) is back on the radar thanks to a cluster of late‑November catalysts: an FDA Type B meeting for lead radiotherapeutic REYOBIQ™, a fresh 180‑day Nasdaq bid‑price extension, and

25 November 2025

Biotech Stocks · FDA Updates · Healthcare Deals · Nasdaq Listings · NASDAQ:PSTV · Stock Market News

VKTX Stock Today, November 25, 2025: Can Viking Therapeutics Keep Riding the Obesity Drug Wave?

Viking Therapeutics (NASDAQ: VKTX) heads into the Tuesday, November 25, 2025 session trading in the mid‑$30s, still digesting last week’s major milestone: the company has finished enrolling patients in its pivotal Phase 3 obesity trial VANQUISH‑1 ahead of schedule and

25 November 2025

Biotech · Investing · Obesity Drugs · Pharmaceuticals · Stock Market

DGNX Stock Today (Nov. 25, 2025): Diginex’s Remedy Project Deal Keeps Volatility — and Valuation Questions — High

Diginex Limited (NASDAQ: DGNX) has become one of 2025’s wildest small-cap stories. The ESG and sustainability RegTech firm has seen its DGNX stock rocket more than 1,100% year-to-date, powered by index inclusion, aggressive M&A plans and a wave of interest

25 November 2025

Financial News · Investment · Market Analysis · NASDAQ:DGNX · Stocks · Technology

Pfizer (PFE) Stock Today: Near‑7% Dividend Yield, Obesity Bet and Pipeline Shift Take Center Stage – November 25, 2025

As investors head into the Tuesday, November 25 session, Pfizer Inc. (NYSE: PFE) remains one of Wall Street’s most closely watched healthcare names. After a brutal comedown from its pandemic-era highs, the drugmaker is trying to convince the market that

25 November 2025

Dividends · Investment Strategies · Market Analysis · Pharma Industry · Stocks